Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.90
0.00 (0.00%)
Dec 26, 2025, 11:44 AM EST - Market open
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $459.67 million as of December 26, 2025. Its market cap has increased by 125.14% in one year.
Market Cap
459.67M
Enterprise Value
245.47M
1-Year Change
125.14%
Ranking
Category
Stock Price
$5.90
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $7.30B to $459.67M, a decrease of -93.70%. That is a compound annual growth rate of -29.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 459.67M | 187.62% |
| Dec 31, 2024 | 159.82M | 29.00% |
| Dec 29, 2023 | 123.89M | 17.92% |
| Dec 30, 2022 | 105.06M | -45.57% |
| Dec 31, 2021 | 193.02M | -61.33% |
| Dec 31, 2020 | 499.18M | 143.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |